Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age75+
SponsorCentre Paul Strauss
About this trial
This is a monocentric, comparative, open-label, randomized parallel group study enrolling elderly subjects hospitalized in Strasbourg Europe Cancerology Institute (ICANS), starting chemotherapy or targeted therapy for the treatment of digestive cancer.
Eligibility criteria
Qualifiers
Patients must be ≥ 75 years old
Performance status 0, 1 or 2
Diagnostic of digestive cancer, all stages (adjuvant or metastatic), with an indication for chemotherapy treatment or targeted therapy for a treatment period of 24 weeks or more
Patients previously treated with one or several lines of chemotherapy for this digestive cancer are eligible
Disqualifiers
History of differentiated neuroendocrine tumors grade 1 or 2 (pancreas, small intestine)
Cancer currently being treated (except for hormone therapy) other than current digestive cancer
History of major surgery and/or curative radiation therapy during the last 4 weeks before inclusion
Patients unable to submit to medical follow-up for geographical, social or psychological reasons
Trial design
Treatments tested in this trial
- EPODIG-G program (coordination of supportive care)
Treatment groups
144 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov